Skip to main content

April 2017

 

 

academics

 

Clinical research courses

The leaked  internal e-mails seem to show employees of one of the world's leading pharmaceutical companies calling for "celebrating" price rises for cancer drugs, a survey revealed.

When the pharmaceutical giant negotiated the price of pharmaceuticals in Spain, the pharmaceutical giant would have threatened to stop selling cancer treatments unless the Minister of Health agreed to price increases of up to 4,000 percent, The Spanish daily El Confidencial Digital said at the time. Price increases were made possible by a loophole that allows pharmaceutical companies to change the price of drugs if they are no longer branded with the same name.

The staff of Aspen Pharmacare, based in South Africa and having its European headquarters in Dublin, would have been traced to destroy stocks of life-saving drugs during a price conflict with the Spanish health service in 2014.

After buying five different cancer drugs from the British company GlaxoSmithKline (GSK), the company tried to sell drugs in Europe up to 40 times their previous price, The Times reported. In 2013, the price of a package of a chemotherapy drug called busulfan, used to treat leukemia, rose from £ 5.20 to £ 65.22 in England and Wales.


<< Back to Pharma News

Subscribe to PharmaTutor News Alerts by Email

Dr. Reddy’s Laboratories Ltd (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced that it has launched Progesterone Capsules, 100 mg and 200 mg, a therapeutic equivalent generic version of Prometrium® (Progesterone) Capsules in the United States market, approved by the U.S. Food and Drug Administration (USFDA).

Novartis announced data from the Phase IV Multiple Sclerosis and clinical outcome and MRI in the US (MS-MRIUS) study, which confirmed the effectiveness of Gilenya® (fingolimod) in the real-world setting, supporting previous findings from Phase III trials. Results show that Gilenya impacted four key measures of MS disease activity (relapses, MRI lesions, disability progression and brain shrinkage), in people with relapsing-remitting multiple sclerosis (RRMS) for up to 16 months. This is also the first time a multicenter study has evaluated and shown that routine magnetic resonance imaging (MRI) scans taken in the every-day clinical setting can reliably be used to measure brain shrinkage, a key measure of disease progression, in people with RRMS. Full results are presented at the 69th American Academy of Neurology (AAN) Annual Meeting, in Boston, Massachusetts, USA.

Recruitment of Pharmacists (40 posts) under District Health Society

RECRUITMENT OF PHARMACIST FOR MOBILE HEALTH TEAMS ON CONTRACT BASIS UNDER RASTRIYA BALA SWASTHYA KARYAKRAM, NATIONAL HEALTH MISSION.

Post: Pharmacist - 40 posts

Career for M.Pharm/M.Sc to work as Project Technical Officer at KGMC

K.G. Medical College has contributed immensely in the education and training of thousands of graduate and post-graduates who have brought glory and laurels to their Alma mater by the academic and professional excellence. On 16th September 2002 an Act was passed by the Government of Uttar Pradesh resulting in a major milestone in change in the history of the institution in converting and upgrading it as Chhatrapati Shahuji Maharaj Medical University.

Work as Safety Processing Expert at Novartis - Master in life Sciences can apply

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Opportunity in J&J for post of District Manager - Metabolics

Caring for the world, one person at a time... inspires and unites the people of Johnson & Johnson. We embrace research and science - bringing innovative ideas, products and services to advance the health and well-being of people. Employees of the Johnson & Johnson Family of Companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.

Vacancy for post of Quality Reviewer, Regulatory Writing at Cactus

CACTUS is a pioneering global scientific communications company. In everything we do, we want to accelerate the development of global scientific research, by helping science break through the confines of geography and language.